Alzheimer Disease

Siemens Medical Solutions Collaborates with Wyeth to Advance Development of New Alzheimer's Therapies

Published in Medical Device Law Weekly, March 25th, 2007

The Molecular Imaging division of Siemens Medical Solutions (www.usa.siemens.com/medical), a leading provider of molecular imaging equipment, molecular imaging tracers and services, announced an agreement with Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), to utilize Siemens' new research imaging agent in Wyeth's clinical studies of new therapies in development for Alzheimer's disease.

"Molecular imaging is rapidly becoming an important element in the drug research and development process," said Michael Reitermann, president, Molecular Imaging, Siemens Medical Solutions. "Molecular imaging is already revolutionizing the detection and diagnosis of diseases like...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Device Law Weekly

Source: Medical Device Law Weekly (2007-03-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry